- Coordinator
- Consorcio Centro De Investigacion Biomedica En Red M.p., Spain
- Runs
- 1 May 2023 to 30 April 2028
- Status
- Running
- EU funding
- €9.9m
- Total cost
- €9.9m
- Partners
- 22 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101080219
What the project is doing
In the project's own words, from its summary on CORDIS.
Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constellation of co-morbidities that seriously hamper individual wellbeing and life-expectancy. Despite major research efforts, obesity treatments have proven of limited efficacy. Thus, effective prevention strategies are essential to avoid the full spectrum of metabolic complications of overweight during the life-course.
Adult obesity is rooted on early maturational events, including pathophysiological and psychological determinants occurring during the gestational, infantile and/or adolescent periods, which globally remain ill defined. Identification of such early pathogenic mechanisms and markers of metabolic disease is key for active prevention and personalized management of body weight disorders later in life. Of note, pathogenic mechanisms and susceptibility to obesity are seemingly gender-dependent, but this aspect remains underexplored and may compromise effectiveness of preventive measures and treatments tackling obesity and its complications. eprObes (for early Prevention of Obesity) is a multidisciplinary, patient-centered project, involving clinical studies targeting different maturational windows, coupled with cognitive, mental health, life-style and behavioral studies, as well as mechanistic analyses in suitable preclinical models, whose major aim is to define effective strategies for active prevention of obesity during the life-course, with particular focus on early developmental events, from prenatal (including peri-conceptional) to pubertal periods, and determinants of feeding behaviors.
Multi-omics studies and integral analysis of eprObes data, assisted by bioinformatic technologies and artificial intelligence, will permit definition of tailored preventive measures and life-style interventions, at key maturational periods, to avoid excessive body weight gain and lifetime metabolic complications in both sexes.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Consorcio Centro De Investigacion Biomedica En Red M.p. | Madrid | Spain | Coordinator |
| Universite De Liege | Liege | Belgium | Participant |
| Eberhard Karls Universitaet Tuebingen | Tuebingen | Germany | Participant |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Sihtasutus Tallinna Lastehaigla | Tallinn | Estonia | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Amaris Espana Estrategia E Innovacion Tecnologica SL | Madrid | Spain | Third party |
| Fundacio Institut D'investigacio Biomedica De Bellvitge | L'Hospitalet De Llobregat | Spain | Third party |
| Fundacion Hospital General Universitario Para La Investigacion Biomedica Docencia Y Desarrollo De Las Ciencias De La Salud | Valencia | Spain | Third party |
| Fundacion Para La Investigacion Biomedica De Cordoba | Cordoba | Spain | Third party |
| Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion Incliva | Valencia | Spain | Third party |
| Premium Research SL | Guadalajara | Spain | Participant |
| Universidad De Cordoba | Cordoba | Spain | Third party |
| Universitat De Valencia | Valencia | Spain | Participant |
| Amaris France SAS | Lyon | France | Third party |
| Amaris Research Unit | Lyon | France | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Paris Labs | Paris | France | Third party |
| Vilniaus Universiteto Ligonine Santaros Klinikos | Vilnius | Lithuania | Participant |
| Uniwersytet Jagiellonski | Krakow | Poland | Participant |
| Uniwersytet Rzeszowski | Rzeszow | Poland | Participant |
| Hipertansiyon Ve Ateroskleroz Dernegi | Istanbul | Türkiye | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI